Acurx PharmaceuticalsACXP
13F holders, Q1 2025 (March 31)24holders −2
5new positions
7sold out
1famous investor
$0.39avg. 13F price*
At the end of Q1 2025, 24 institutions reported holding Acurx Pharmaceuticals Inc. (ACXP) in their 13F filings, down 2 from Q4 2024. 5 opened new positions and 7 sold out. The largest holders were Sabby Management, LLC ($797K), Vanguard Group Inc. ($206K) and Prospect Financial Services LLC ($143K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Acurx Pharmaceuticals Inc.
- CUSIP
- 00510M104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $828K |
| Exits | 7 | $115K |
All 13F filers, Q4 2024 → Q1 2025: 2,206,260 shares bought and 153,090 shares sold, net +2,053,170 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Sabby Management, LLC | 3.35% | New | 2,044,546 | $797K |
| Vanguard Group Inc. | 0.00% | No change | 529,349 | $206K |
| Prospect Financial Services LLC | 0.08% | Add +11.4% | 366,576 | $143K |
| Geode Capital Management, LLC | 0.00% | Add +17.1% | 171,487 | $67K |
| Morgan Stanley | 0.00% | No change | 106,201 | $41K |
| Vanguard Capital Wealth Advisors | 0.03% | New | 67,500 | $26K |
| State Street Corp. | 0.00% | No change | 43,466 | $17K |
| BlackRock, Inc. | 0.00% | Add +32.2% | 34,245 | $13K |
| Lanark Financial, Inc. | 0.00% | — | 30,000 | $11K |
| Northern Trust Corp. | 0.00% | No change | 27,286 | $11K |
| Renaissance Technologies | 0.00% | Add +81.3% | 26,600 | $10K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Reduce -15.5% | 15,000 | $6K |
| Quartz Partners, LLC | 0.00% | New | 10,000 | $4K |
| Osaic Holdings, Inc. | 0.00% | Reduce -18.3% | 9,582 | $4K |
| Semmax Financial Advisors Inc. | 0.00% | Reduce -21.4% | 5,640 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.8% | 4,411 | $2K |
| Cornerstone Planning Group LLC | 0.00% | No change | 3,344 | $1K |
| Group One Trading LLC | 0.00% | No change | 1,165 | $454 |
| GPS Wealth Strategies Group, LLC | 0.00% | No change | 500 | $195 |
| SBI Securities Co., Ltd. | 0.00% | Add +5.2% | 284 | $111 |
| Bank of America Corp. | 0.00% | Add +20.5% | 141 | $55 |
| UBS Group AG | 0.00% | Reduce -99.2% | 47 | $18 |
| JPMorgan Chase & Co. | 0.00% | New | 29 | $11 |
| Simplex Trading, LLC | 0.00% | New | 1,400 | $0 |
"% of holder's portfolio" is ACXP's weight in each manager's 13F, not the share of Acurx Pharmaceuticals Inc. the manager owns.